Indivior Pharmaceuticals Declares $8.13 Special Dividend

By Greg Peters • Thursday, September 17 10:52 • Permanent Link

Indivior Pharmaceuticals declared a special cash dividend of $8.13 per share, but the payout is tied to the closing of its pending merger with Supernus Pharmaceuticals.

The dividend will go to two groups: Holders of record of Indivior common stock as of Oct. 30, 2026 Holders of certain Indivior equity awards outstanding as of that date, with the same $8.13 per share amount payable when those awards vest

If the merger closes as expected, the dividend would be paid on or about Nov. 6, 2026. Indivior said the merger is expected to be completed on or about Nov. 2, 2026.

The company said the special dividend will not be paid if the merger is not completed for any reason. Supernus shareholders will not receive the dividend on Indivior shares they get in the deal.

The announcement comes just days after Indivior filed the joint proxy statement/prospectus for the transaction on Sept. 11, 2026. The market has reacted to these announcements by moving the company's shares 3.73% to a price of $35.63. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.